褪黑素（MEL）及其在昼夜节律睡眠-觉醒障碍中的应用：法国医学和研究睡眠学会（SFRMS）的建议。
Melatonin (MEL) and its use in circadian rhythm sleep-wake disorders: Recommendations of the French Medical and Research Sleep Society (SFRMS).
机构信息
Sleep Disorders Unit, Département de Physiology, Hôpital Raymond-Poincaré, Université de Saclay, EA 4047, AP-HP, Saclay University, 92380 Garches, France.
Sleep Disorders Center, Hôpitaux Universitaires de Strasbourg, Institut des neurosciences cellulaires et intégratives, CNRS-UPR 3212, 5, rue Blaise-Pascal, 67000 Strasbourg, France.
出版信息
Rev Neurol (Paris). 2021 Mar;177(3):235-244. doi: 10.1016/j.neurol.2020.07.021. Epub 2021 Jan 11.
The French society of medical research on sleep (SFRMS) appointed a group of experts to conduct a consensus conference in order to study the indications and prescription status of exogenous melatonin (MEL). Eleven sleep physicians/researchers investigated in subgroups the use of MEL in different domains of healthcare in line with their subspecialties (circadian sleep/wake rhythm disorders, psychiatric disorders, neurological disorders, pediatric and neurodevelopmental disorders). In this article we present a summary of the main conclusions of the expert group on MEL therapy in circadian sleep/wake rhythm disorders such us delayed sleep-wake disorder, non-24-hour sleep wake rhythm disorder and jet lag.
法国医学睡眠研究学会（SFRMS）任命了一组专家进行共识会议，以研究外源性褪黑素（MEL）的适应症和处方状态。11 名睡眠医师/研究人员根据其专业领域（昼夜睡眠/觉醒节律障碍、精神障碍、神经障碍、儿科和神经发育障碍）在亚组中调查了 MEL 在不同医疗保健领域的使用情况。在本文中，我们总结了专家组关于 MEL 治疗昼夜睡眠/觉醒节律障碍（如睡眠-觉醒时相延迟障碍、非 24 小时睡眠-觉醒节律障碍和时差）的主要结论。
Zotero 插件